Trending...
- Liquidity Aggregation: US-Registered JHKXWL Integrates AI Analytics for Brazilian and Global Institutional Traders - 497
- For Write a Business Plan Month:This MARKETING MATH can help you MAKE A LOT MORE MONEY a lot Faster!
- ProfileSpider Launches Powerful One-Click Profile Scraper for Recruiters and Growth Teams
A plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 hydrolase activity.
MILPITAS, Calif. - Californer -- Cluster of differentiation 38 (CD38), also known as cyclic ADP ribose hydrolase is a type II transmembrane glycoprotein that can function either as a receptor or as an enzyme. It is found on the surface of many immune cells, including plasma B cells, natural killer cells, CD4+, CD8+ etc. It is a multifunctional enzyme involved in cell-adhesion, calcium signaling and Nicotinamide Adenine Dinucleotide (NAD+) metabolism. The hydrolase activity of CD38 helps maintain the appropriate levels of NAD+ for all NAD+ dependent metabolic processes to occur. Elevated levels of CD38 are associated with aging, obesity, diabetes, heart disease, asthma, inflammation and tumorigenesis etc.
More on The Californer
BioVision's CD38 (Hydrolase) Inhibitor Screening Kit is a plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 hydrolase activity. The assay utilizes a selective CD38 substrate to generate a fluorescent signal measured at Ex/Em = 300/410 nm. In the presence of potential CD38 hydrolase inhibitors, the fluorescent signal is reduced. The assay is quick, easy, and sensitive for high-throughput screening of CD38 inhibitors. Additionally, the kit includes a CD38 Inhibitor as a control inhibitor.
Figure: Inhibition of CD38 activity by Apigenin. IC50 was calculated to be 6.1 ± 0.1 μM. Assay was performed following the kit protocol.
For more information on this Assay Kit Cat# K2086, Visit: https://bit.ly/3ofloCb
More on The Californer
- Richline Transportation Expands Luxury San Diego Airport to LAX Car Service
- Landon Brittain Supports Holiday Charity Efforts at Teddy Ball 2025
- Snell & Wilmer's San Diego Office Welcomes Associate Chad Thurston
- America's Most Festive Garages Wanted for Garage.com's 2025 Holiday Contest
- JiT Home Buyers Increases Coverage Across U.S. States and Major Metro Regions
BioVision's CD38 (Hydrolase) Inhibitor Screening Kit is a plate-based fluorometric assay designed to screen, study and characterize potential inhibitors of CD38 hydrolase activity. The assay utilizes a selective CD38 substrate to generate a fluorescent signal measured at Ex/Em = 300/410 nm. In the presence of potential CD38 hydrolase inhibitors, the fluorescent signal is reduced. The assay is quick, easy, and sensitive for high-throughput screening of CD38 inhibitors. Additionally, the kit includes a CD38 Inhibitor as a control inhibitor.
Figure: Inhibition of CD38 activity by Apigenin. IC50 was calculated to be 6.1 ± 0.1 μM. Assay was performed following the kit protocol.
For more information on this Assay Kit Cat# K2086, Visit: https://bit.ly/3ofloCb
Source: BioVision, Inc.
0 Comments
Latest on The Californer
- Pythagoras AI Announces Selection by ChenMed for Value-Based Care Conversational AI Agent Use
- FDA Accepts ANDA for KETAFREE™ as Analyst Sets $34 Price Target for NRx Pharmaceuticals: (N A S D A Q : NRXP) NRx is Poised for a massive Breakthrough
- Impact & Influence Magazine and Awepra Announce Strategic Relocation to 500 Capitol Mall
- City of Long Beach to Offer Annual Holiday Treecycling Program
- BEC Technologies Expands MX-220 5G Industrial Router Series for Edge Connectivity
- "Latino Leaders Speak: Personal Stories of Struggle and Triumph, Volume II" Documents the Truth About Latino Excellence and Impact on American Society
- Broadway Smile Boutique Unveils Modern Website for Enhanced Patient Experience
- Fenix Consulting Group Expands Orange County Office to Meet Growing Client Demand
- Signature Smiles Dental Group Unveils New User-Friendly Website
- CCHR: New Data Shows Millions of U.S. Children Caught in Escalating Psychiatric Polypharmacy
- QwickContractReview.com Launches $19 Contract Review Service to Protect Consumers from Hidden Contract Risks
- National Champion Collegiate Esports Program Faces Closure
- Mike Diamond Plumbing, HVAC & Electrical Launches $45 Off Toilet Installation Special
- Ermoleve Christmas Sale 2025: Up to 40% Off Your Favourite Jewellery
- IODJ Digital Asset Hub Expands Transparency Framework With New Operational Disclosure Layer
- Tuvalor Exchange Announces New Stability and Performance Upgrade
- The ROS1ders Announces Recipients of the 2025 ROS1+ Cancer Innovation Award
- Greluna Exchange Introduces Enhanced Market Data Feeds for Institutional Users
- Laurie McLennan Named Top Agent at Desert Sotheby's International Realty in La Quinta
- Official City of Long Beach Statement on the Passing of Former Mayor Robert "Bob" Foster